Fc Receptor Binding Engineering
Fc Receptor Binding Engineering is a methodological framework within antibody engineering that specifically involves the rational modification of the fragment crystallizable (Fc) region of immunoglobulins to modulate selective interactions with Fc receptors, thereby enhancing or suppressing downstream immune effector functions.
68
Publications
3.7K
Citations
475
Authors
131
Institutions
Publications per year
2017–2026
16
Parents
68
Amita Datta‐Mannan, Derrick R. Witcher, Ying Tang et al. · Journal of Biological Chemistry · 2006 · 163 citations · Full text
Pharmacy, Immunology, Pharmacology +17
1–5 of 68
475
4
h-index
4
h-index
4
h-index
3
h-index
3
h-index
1–5 of 475
131
Xencor (United States)
Monrovia, United States
6 h-index
50 publications
3K citations

KTH Royal Institute of Technology
Stockholm, Sweden
3 h-index
7 publications
259 citations

University of Oslo
Oslo, Norway
3 h-index
4 publications
218 citations

Aarhus University
Aarhus, Denmark
3 h-index
11 publications
267 citations

Christian-Albrechts-Universität zu Kiel
Kiel, Germany
3 h-index
11 publications
537 citations
University of California, Los Angeles
Los Angeles, United States
2 h-index
8 publications
277 citations
Roche (Switzerland)
Basel, Switzerland
2 h-index
15 publications
343 citations
UCB Pharma (United Kingdom)
Slough, United Kingdom
2 h-index
14 publications
376 citations
1–8 of 131
8 publications · 338 citations
8
h-index
5 publications · 268 citations
5
h-index
4 publications · 207 citations
4
h-index
4 publications · 141 citations
4
h-index
JBC · 3 publications · 863 citations
3
h-index
1–5